Leaf Pharma

LuciLazer 80mg is a branded formulation of Lazertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It is specifically developed for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations, particularly those with the T790M resistance mutation. LuciLazer offers a targeted, oral therapy approach for patients who have progressed on earlier-generation EGFR TKIs.

What is LuciLazer 80mg?

LuciLazer 80mg contains Lazertinib, an orally administered anti-cancer drug used in EGFR-mutated NSCLC. It is a potent and selective inhibitor of EGFR mutations, including the common activating mutations (exon 19 deletions and L858R) and the T790M resistance mutation, making it valuable in overcoming acquired resistance to first- and second-generation EGFR TKIs.

How it Works / Mechanism of Action

Lazertinib targets mutated EGFR in cancer cells. EGFR is a receptor tyrosine kinase that, when activated abnormally due to mutations, leads to uncontrolled cell division and tumor growth.

Lazertinib selectively:

• Binds irreversibly to the mutant EGFR kinase domain.

• Inhibits phosphorylation of EGFR and downstream signaling pathways such as PI3K/AKT and MAPK, essential for tumor cell proliferation and survival.

• Overcomes T790M mutation-based resistance seen in patients previously treated with other EGFR inhibitors like erlotinib or gefitinib.

• Its high selectivity for mutant EGFR reduces off-target toxicity, particularly sparing wild-type EGFR to minimize skin and gastrointestinal side effects.

How to Use / Indications

LuciLazer 80mg is primarily indicated for:

• Advanced or metastatic NSCLC patients with EGFR T790M mutation.

• Patients whose disease has progressed on or after EGFR TKI therapy (like erlotinib or gefitinib).

• It may be used as a second-line or later-line treatment after confirmation of the mutation by an FDA-approved test.

How to Take / Dosage

• Standard Dosage: One tablet of LuciLazer 80mg taken orally once daily.

• It should be taken at the same time each day, with or without food.

• Swallow the tablet whole with water. Do not chew or crush.

Other Dosage Forms / Strengths

As of current data:

• LuciLazer is primarily available as 80mg tablets.

• Clinical studies have evaluated other doses (e.g., 40mg and 240mg), but 80mg has shown an optimal balance of efficacy and safety.

• Dose adjustments may be required for patients experiencing Grade 3 or higher toxicities, depending on physician guidance.

Side EffectsCommon side effects:

• Rash

• Diarrhea

• Stomatitis

• Decreased appetite

• Dry skin

• Nail inflammation

Serious side effects:

• Interstitial Lung Disease

• QT prolongation

• Hepatotoxicity

• Vision disturbances

• Bone marrow suppression

• Routine monitoring through blood tests, liver function tests, and ECGs is recommended during therapy.

Storage

• Store at room temperature (20°C to 25°C or 68°F to 77°F).

• Protect from moisture and light.

• Keep the medication in its original container.

• Keep out of reach of children and pets.

• Do not use beyond the expiry date on the label.

Benefits

LuciLazer 80mg offers several clinical advantages:

• Targeted Action

• Effective Against T790M Mutation

• Oral Convenience

• Reduced Skin Toxicity